Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Dalbavancin (Primary) ; Dalbavancin (Primary)
- Indications Bacterial peritonitis
- Focus Pharmacokinetics
- 22 Jan 2018 Status changed from not yet recruiting to recruiting.
- 10 Jan 2018 Planned initiation date changed from 1 Aug 2017 to 1 Feb 2018.
- 17 Jul 2017 Planned initiation date changed from 1 Jun 2017 to 1 Aug 2017.